<1. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 27358386 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - MEDLINE AU - Koessler T AU - Olivier T AU - Fertani S AU - Marinari E AU - Dutoit V AU - Dietrich PY FA - Koessler, T FA - Olivier, T FA - Fertani, S FA - Marinari, E FA - Dutoit, V FA - Dietrich, P-Y IN - Koessler, T. Center of Oncology thibaud.kossler@hcuge.ch. IN - Olivier, T. Center of Oncology. IN - Fertani, S. Center of Oncology. IN - Marinari, E. Center of Oncology Laboratory of Tumor Immunology, Hopitaux Universitaires de Geneve, Geneva, Switzerland. IN - Dutoit, V. Center of Oncology Laboratory of Tumor Immunology, Hopitaux Universitaires de Geneve, Geneva, Switzerland. IN - Dietrich, P-Y. Center of Oncology Laboratory of Tumor Immunology, Hopitaux Universitaires de Geneve, Geneva, Switzerland. TI - Ipilimumab-related hypophysitis may precede severe CNS immune attack. SO - Annals of Oncology. 27(10):1975-6, 2016 10 AS - Ann Oncol. 27(10):1975-6, 2016 10 NJ - Annals of oncology : official journal of the European Society for Medical Oncology VO - 27 IP - 10 PG - 1975-6 PI - Journal available in: Print-Electronic PI - Citation processed from: Internet JC - ayf, 9007735 IO - Ann. Oncol. SB - Index Medicus CP - England MH - *Antineoplastic Agents, Immunological/ae [Adverse Effects] MH - Female MH - Humans MH - *Hypophysitis/ci [Chemically Induced] MH - Hypophysitis/di [Diagnosis] MH - *Hypophysitis/im [Immunology] MH - *Ipilimumab/ae [Adverse Effects] MH - Middle Aged MH - *Severity of Illness Index RN - 0 (Antineoplastic Agents, Immunological) RN - 0 (Ipilimumab) ES - 1569-8041 IL - 0923-7534 DO - https://dx.doi.org/10.1093/annonc/mdw255 PT - Case Reports PT - Letter ID - mdw255 [pii] ID - 10.1093/annonc/mdw255 [doi] PP - ppublish LG - English EP - 20160629 DP - 2016 10 EZ - 2016/07/01 06:00 DA - 2018/01/24 06:00 DT - 2016/07/01 06:00 YR - 2016 ED - 20180123 RD - 20180123 UP - 20180124 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=medl&AN=27358386 <2. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 27029705 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - MEDLINE AU - Zschabitz S AU - Lasitschka F AU - Jager D AU - Grullich C FA - Zschabitz, S FA - Lasitschka, F FA - Jager, D FA - Grullich, C IN - Zschabitz, S. Department of Medical Oncology, National Center for Tumor Diseases (NCT). IN - Lasitschka, F. Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany. IN - Jager, D. Department of Medical Oncology, National Center for Tumor Diseases (NCT). IN - Grullich, C. Department of Medical Oncology, National Center for Tumor Diseases (NCT) carsten.gruellich@med.uni-heidelberg.de. TI - Activity of immune checkpoint inhibition in platinum refractory germ-cell tumors. SO - Annals of Oncology. 27(7):1356-60, 2016 07 AS - Ann Oncol. 27(7):1356-60, 2016 07 NJ - Annals of oncology : official journal of the European Society for Medical Oncology VO - 27 IP - 7 PG - 1356-60 PI - Journal available in: Print-Electronic PI - Citation processed from: Internet JC - ayf, 9007735 IO - Ann. Oncol. SB - Index Medicus CP - England MH - Adult MH - Antibodies, Monoclonal/pd [Pharmacology] MH - Antibodies, Monoclonal/tu [Therapeutic Use] MH - Antibodies, Monoclonal, Humanized/pd [Pharmacology] MH - Antibodies, Monoclonal, Humanized/tu [Therapeutic Use] MH - Antineoplastic Agents/pd [Pharmacology] MH - Antineoplastic Agents/tu [Therapeutic Use] MH - Antineoplastic Agents, Immunological/pd [Pharmacology] MH - *Antineoplastic Agents, Immunological/tu [Therapeutic Use] MH - Cisplatin/pd [Pharmacology] MH - *Cisplatin/tu [Therapeutic Use] MH - *Drug Resistance, Neoplasm/de [Drug Effects] MH - Humans MH - Male MH - Neoplasms, Germ Cell and Embryonal/dg [Diagnostic Imaging] MH - *Neoplasms, Germ Cell and Embryonal/dt [Drug Therapy] MH - Platinum/tu [Therapeutic Use] MH - *Programmed Cell Death 1 Receptor/ai [Antagonists & Inhibitors] MH - Testicular Neoplasms/dg [Diagnostic Imaging] MH - *Testicular Neoplasms/dt [Drug Therapy] RN - 0 (Antibodies, Monoclonal) RN - 0 (Antibodies, Monoclonal, Humanized) RN - 0 (Antineoplastic Agents) RN - 0 (Antineoplastic Agents, Immunological) RN - 0 (PDCD1 protein, human) RN - 0 (Programmed Cell Death 1 Receptor) RN - 31YO63LBSN (nivolumab) RN - 49DFR088MY (Platinum) RN - DPT0O3T46P (pembrolizumab) RN - Q20Q21Q62J (Cisplatin) ES - 1569-8041 IL - 0923-7534 DO - https://dx.doi.org/10.1093/annonc/mdw146 PT - Case Reports PT - Letter ID - mdw146 [pii] ID - 10.1093/annonc/mdw146 [doi] PP - ppublish LG - English EP - 20160330 DP - 2016 07 EZ - 2016/04/01 06:00 DA - 2018/01/24 06:00 DT - 2016/04/01 06:00 YR - 2016 ED - 20180123 RD - 20180123 UP - 20180124 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=medl&AN=27029705 <3. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 29050806 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - MEDLINE AU - Strik H AU - Keber U AU - Hammoud WA AU - Riera-Knorrenschild J AU - Carl B AU - Dodel R AU - Pagenstecher A AU - Neubauer A FA - Strik, Herwig FA - Keber, Ursula FA - Hammoud, Wasim Alhaj FA - Riera-Knorrenschild, Jorge FA - Carl, Barbara FA - Dodel, Richard FA - Pagenstecher, Axel FA - Neubauer, Andreas IN - Strik, Herwig. Department of Neurology, Philipps-University, Marburg, Germany. Electronic address: strik@med.uni-marburg.de. IN - Keber, Ursula. Department of Neuropathology, Philipps-University, Marburg, Germany. IN - Hammoud, Wasim Alhaj. Department of Neuroradiology, Philipps-University, Marburg, Germany. IN - Riera-Knorrenschild, Jorge. Department of Hematology, Oncology, Immunology, Philipps-University, Marburg, Germany. IN - Carl, Barbara. Department of Neurosurgery, Philipps-University, Marburg, Germany. IN - Dodel, Richard. Department of Neurology, Philipps-University, Marburg, Germany. IN - Pagenstecher, Axel. Department of Neuropathology, Philipps-University, Marburg, Germany. IN - Neubauer, Andreas. Department of Hematology, Oncology, Immunology, Philipps-University, Marburg, Germany. TI - Immune checkpoint inhibitor-associated CNS autoimmune disorder (ICICAD) following nivolumab treatment: A new entity of drug-induced autoimmune encephalitis?. SO - European Journal of Cancer. 87:205-208, 2017 12 AS - Eur J Cancer. 87:205-208, 2017 12 NJ - European journal of cancer (Oxford, England : 1990) VO - 87 PG - 205-208 PI - Journal available in: Print-Electronic PI - Citation processed from: Internet JC - arv, 9005373 IO - Eur. J. Cancer SB - Index Medicus CP - England MH - *Antibodies, Monoclonal/ae [Adverse Effects] MH - *Antineoplastic Agents/ae [Adverse Effects] MH - *Encephalitis/ci [Chemically Induced] MH - *Hashimoto Disease/ci [Chemically Induced] MH - Humans MH - *Lymphoma, B-Cell/dt [Drug Therapy] MH - Male MH - Middle Aged RN - 0 (Antibodies, Monoclonal) RN - 0 (Antineoplastic Agents) RN - 31YO63LBSN (nivolumab) RS - Hashimoto's encephalitis ES - 1879-0852 IL - 0959-8049 DI - S0959-8049(17)31307-2 DO - https://dx.doi.org/10.1016/j.ejca.2017.09.026 PT - Case Reports PT - Letter ID - S0959-8049(17)31307-2 [pii] ID - 10.1016/j.ejca.2017.09.026 [doi] PP - ppublish PH - 2017/02/26 [received] PH - 2017/09/07 [revised] PH - 2017/09/12 [accepted] LG - English EP - 20171016 DP - 2017 12 EZ - 2017/10/21 06:00 DA - 2018/01/11 06:00 DT - 2017/10/21 06:00 YR - 2017 ED - 20180110 RD - 20180110 UP - 20180111 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=medl&AN=29050806 <4. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 27178147 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - MEDLINE AU - Ishikawa M AU - Oashi K FA - Ishikawa, Masashi FA - Oashi, Kohei IN - Ishikawa, Masashi. Department of Dermatology, Saitama Cancer Center, Saitama, Japan. IN - Oashi, Kohei. Department of Dermatology, Saitama Cancer Center, Saitama, Japan. TI - Case of hypophysitis caused by nivolumab. SO - Journal of Dermatology. 44(1):109-110, 2017 Jan AS - J Dermatol. 44(1):109-110, 2017 Jan NJ - The Journal of dermatology VO - 44 IP - 1 PG - 109-110 PI - Journal available in: Print-Electronic PI - Citation processed from: Internet JC - hz7, 7600545 IO - J. Dermatol. SB - Index Medicus CP - England MH - Adrenal Insufficiency/bl [Blood] MH - Adrenal Insufficiency/dt [Drug Therapy] MH - *Adrenal Insufficiency/et [Etiology] MH - Adrenocorticotropic Hormone/bl [Blood] MH - Anorexia/et [Etiology] MH - *Antibodies, Monoclonal/ae [Adverse Effects] MH - Antibodies, Monoclonal/tu [Therapeutic Use] MH - *Antineoplastic Agents/ae [Adverse Effects] MH - Antineoplastic Agents/tu [Therapeutic Use] MH - Conjunctiva MH - Dacarbazine/tu [Therapeutic Use] MH - Hormone Replacement Therapy MH - Humans MH - Hydrocortisone/ad [Administration & Dosage] MH - Hydrocortisone/bl [Blood] MH - Hydrocortisone/tu [Therapeutic Use] MH - Hypophysitis/bl [Blood] MH - *Hypophysitis/ci [Chemically Induced] MH - Hypophysitis/co [Complications] MH - Hypophysitis/dg [Diagnostic Imaging] MH - Hypothyroidism/ci [Chemically Induced] MH - Lung Diseases, Interstitial/ci [Chemically Induced] MH - Magnetic Resonance Imaging MH - Male MH - *Melanoma/dt [Drug Therapy] MH - Middle Aged MH - Myalgia/et [Etiology] MH - Nausea/et [Etiology] MH - Programmed Cell Death 1 Receptor/ai [Antagonists & Inhibitors] MH - Withholding Treatment RN - 0 (Antibodies, Monoclonal) RN - 0 (Antineoplastic Agents) RN - 0 (PDCD1 protein, human) RN - 0 (Programmed Cell Death 1 Receptor) RN - 31YO63LBSN (nivolumab) RN - 7GR28W0FJI (Dacarbazine) RN - 9002-60-2 (Adrenocorticotropic Hormone) RN - WI4X0X7BPJ (Hydrocortisone) ES - 1346-8138 IL - 0385-2407 DO - https://dx.doi.org/10.1111/1346-8138.13437 PT - Case Reports PT - Letter ID - 10.1111/1346-8138.13437 [doi] PP - ppublish LG - English EP - 20160514 DP - 2017 Jan EZ - 2016/05/15 06:00 DA - 2017/07/18 06:00 DT - 2016/05/15 06:00 YR - 2017 ED - 20170717 RD - 20170717 UP - 20171128 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med8&AN=27178147 <5. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 26883763 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - MEDLINE AU - Vancieri G AU - Bellia A AU - Lauro D FA - Vancieri, G FA - Bellia, A FA - Lauro, D IN - Vancieri, G. Division of Endocrinology and Diabetology, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy. IN - Bellia, A. Division of Endocrinology and Diabetology, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy. IN - Lauro, D. Division of Endocrinology and Diabetology, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy. d.lauro@med.uniroma2.it. TI - Late-onset panhypopituitarism in a 72-year-old male patient treated with ipilimumab for metastatic melanoma: a case report. SO - Journal of Endocrinological Investigation. 39(7):805-6, 2016 Jul AS - J Endocrinol Invest. 39(7):805-6, 2016 Jul NJ - Journal of endocrinological investigation VO - 39 IP - 7 PG - 805-6 PI - Journal available in: Print-Electronic PI - Citation processed from: Internet JC - iam, 7806594 IO - J. Endocrinol. Invest. SB - Index Medicus CP - Italy MH - Age of Onset MH - Aged MH - *Antibodies, Monoclonal/ae [Adverse Effects] MH - Humans MH - *Hypopituitarism/ci [Chemically Induced] MH - *Hypopituitarism/di [Diagnosis] MH - Ipilimumab MH - Male MH - *Melanoma/dt [Drug Therapy] MH - Melanoma/sc [Secondary] RN - 0 (Antibodies, Monoclonal) RN - 0 (Ipilimumab) RS - Combined Pituitary Hormone Deficiency ES - 1720-8386 IL - 0391-4097 DO - https://dx.doi.org/10.1007/s40618-016-0439-3 PT - Case Reports PT - Letter ID - 10.1007/s40618-016-0439-3 [doi] ID - 10.1007/s40618-016-0439-3 [pii] PP - ppublish PH - 2015/12/14 [received] PH - 2016/02/02 [accepted] LG - English EP - 20160216 DP - 2016 Jul EZ - 2016/02/18 06:00 DA - 2017/04/26 06:00 DT - 2016/02/18 06:00 YR - 2016 ED - 20170425 RD - 20171116 UP - 20171128 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med8&AN=26883763 <6. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 27376434 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - MEDLINE AU - Humayun MA AU - Poole R FA - Humayun, Malik Asif FA - Poole, Ruth IN - Humayun, Malik Asif. Royal Bournemouth Hospital, Bournemouth, UK. IN - Poole, Ruth. Poole Hospital, NHS Foundation Trust, Poole; UK. TI - A case of multiple immune toxicities from Ipilimumab and pembrolizumab treatment. SO - Hormones. 15(2):303-6, 2016 Apr AS - Hormones. 15(2):303-6, 2016 Apr NJ - Hormones (Athens, Greece) VO - 15 IP - 2 PG - 303-6 PI - Journal available in: Print PI - Citation processed from: Internet JC - 101142469 IO - Hormones (Athens) SB - Index Medicus CP - Greece MH - *Antibodies, Monoclonal/ae [Adverse Effects] MH - *Antibodies, Monoclonal, Humanized/ae [Adverse Effects] MH - *Diabetes Mellitus, Type 1/ci [Chemically Induced] MH - Diabetes Mellitus, Type 1/di [Diagnosis] MH - Diabetes Mellitus, Type 1/im [Immunology] MH - Humans MH - *Hypophysitis/ci [Chemically Induced] MH - Hypophysitis/di [Diagnosis] MH - Hypophysitis/im [Immunology] MH - Ipilimumab MH - Male MH - *Melanoma/dt [Drug Therapy] MH - Melanoma/im [Immunology] MH - Melanoma/sc [Secondary] MH - Middle Aged MH - Risk Factors MH - *Skin Neoplasms/dt [Drug Therapy] MH - Skin Neoplasms/im [Immunology] MH - Skin Neoplasms/pa [Pathology] RN - 0 (Antibodies, Monoclonal) RN - 0 (Antibodies, Monoclonal, Humanized) RN - 0 (Ipilimumab) RN - DPT0O3T46P (pembrolizumab) IS - 1109-3099 IL - 1109-3099 DO - https://dx.doi.org/10.14310/horm.2002.1656 PT - Case Reports PT - Letter ID - 10.14310/horm.2002.1656 [doi] PP - ppublish PH - 2015/12/22 [received] PH - 2016/01/27 [accepted] LG - English DP - 2016 Apr EZ - 2016/07/05 06:00 DA - 2017/04/18 06:00 DT - 2016/07/05 06:00 YR - 2016 ED - 20170417 RD - 20171116 UP - 20171128 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med8&AN=27376434 <7. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 27067877 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - MEDLINE AU - Hansen E AU - Sahasrabudhe D AU - Sievert L FA - Hansen, Elizabeth FA - Sahasrabudhe, Deepak FA - Sievert, Lynn IN - Hansen, Elizabeth. University of Rochester Medical Center, 601 Elmwood Avenue, Box 617, Rochester, NY, 14642, USA. Elizabeth_hansen@urmc.rochester.edu. IN - Sahasrabudhe, Deepak. University of Rochester Medical Center, 601 Elmwood Avenue, Box 617, Rochester, NY, 14642, USA. IN - Sievert, Lynn. University of Rochester Medical Center, 601 Elmwood Avenue, Box 617, Rochester, NY, 14642, USA. TI - A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome. CM - Comment in: Cancer Immunol Immunother. 2016 Jun;65(6):769-70; PMID: 27194054 SO - Cancer Immunology, Immunotherapy. 65(6):765-7, 2016 06 AS - Cancer Immunol Immunother. 65(6):765-7, 2016 06 NJ - Cancer immunology, immunotherapy : CII VO - 65 IP - 6 PG - 765-7 PI - Journal available in: Print-Electronic PI - Citation processed from: Internet JC - cn3, 8605732 IO - Cancer Immunol. Immunother. SB - Index Medicus CP - Germany MH - *Antibodies, Monoclonal, Humanized/ae [Adverse Effects] MH - Antibodies, Monoclonal, Humanized/tu [Therapeutic Use] MH - *Antineoplastic Agents/ae [Adverse Effects] MH - Antineoplastic Agents/tu [Therapeutic Use] MH - Antineoplastic Combined Chemotherapy Protocols/ae [Adverse Effects] MH - Antineoplastic Combined Chemotherapy Protocols/tu [Therapeutic Use] MH - Diabetes Mellitus, Type 1/di [Diagnosis] MH - *Diabetes Mellitus, Type 1/et [Etiology] MH - Diabetes Mellitus, Type 1/th [Therapy] MH - Disease Management MH - Humans MH - Insulins/ad [Administration & Dosage] MH - Insulins/tu [Therapeutic Use] MH - Male MH - Melanoma/co [Complications] MH - Melanoma/di [Diagnosis] MH - Melanoma/dt [Drug Therapy] MH - Middle Aged MH - Molecular Targeted Therapy/ae [Adverse Effects] MH - Patient Outcome Assessment MH - Programmed Cell Death 1 Receptor/ai [Antagonists & Inhibitors] MH - Skin Neoplasms MH - Treatment Outcome RN - 0 (Antibodies, Monoclonal, Humanized) RN - 0 (Antineoplastic Agents) RN - 0 (Insulins) RN - 0 (Programmed Cell Death 1 Receptor) RN - DPT0O3T46P (pembrolizumab) RS - Melanoma, Cutaneous Malignant ES - 1432-0851 IL - 0340-7004 DO - https://dx.doi.org/10.1007/s00262-016-1835-4 PT - Case Reports PT - Letter ID - 10.1007/s00262-016-1835-4 [doi] ID - 10.1007/s00262-016-1835-4 [pii] PP - ppublish PH - 2015/11/25 [received] PH - 2016/03/29 [accepted] LG - English EP - 20160411 DP - 2016 06 EZ - 2016/04/14 06:00 DA - 2017/02/07 06:00 DT - 2016/04/13 06:00 YR - 2016 ED - 20170206 RD - 20171116 UP - 20171128 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med8&AN=27067877 <8. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 26116720 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - MEDLINE AU - Mellati M AU - Eaton KD AU - Brooks-Worrell BM AU - Hagopian WA AU - Martins R AU - Palmer JP AU - Hirsch IB FA - Mellati, Mahnaz FA - Eaton, Keith D FA - Brooks-Worrell, Barbara M FA - Hagopian, William A FA - Martins, Renato FA - Palmer, Jerry P FA - Hirsch, Irl B IN - Mellati, Mahnaz. Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA. IN - Eaton, Keith D. Division of Medical Oncology, University of Washington, Seattle, WA. IN - Brooks-Worrell, Barbara M. Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA Division of Endocrinology, VA Puget Sound Health Care System, Seattle, WA. IN - Hagopian, William A. Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA Pacific Northwest Diabetes Research Institute, Seattle, WA. IN - Martins, Renato. Division of Medical Oncology, University of Washington, Seattle, WA. IN - Palmer, Jerry P. Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA Division of Endocrinology, VA Puget Sound Health Care System, Seattle, WA. IN - Hirsch, Irl B. Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA ihirsch@uw.edu. TI - Anti-PD-1 and Anti-PDL-1 Monoclonal Antibodies Causing Type 1 Diabetes. SO - Diabetes Care. 38(9):e137-8, 2015 Sep AS - Diabetes Care. 38(9):e137-8, 2015 Sep NJ - Diabetes care VO - 38 IP - 9 PG - e137-8 PI - Journal available in: Print-Electronic PI - Citation processed from: Internet JC - eag, 7805975 IO - Diabetes Care SB - Index Medicus CP - United States MH - Adenocarcinoma/dt [Drug Therapy] MH - Adenocarcinoma/im [Immunology] MH - Aged MH - *Antibodies, Monoclonal/ae [Adverse Effects] MH - Antibodies, Monoclonal/tu [Therapeutic Use] MH - *B7-H1 Antigen/im [Immunology] MH - Carcinoma, Squamous Cell/dt [Drug Therapy] MH - Carcinoma, Squamous Cell/im [Immunology] MH - *Diabetes Mellitus, Type 1/et [Etiology] MH - Diabetes Mellitus, Type 1/im [Immunology] MH - Diabetic Ketoacidosis/ci [Chemically Induced] MH - Diabetic Ketoacidosis/im [Immunology] MH - Female MH - Head and Neck Neoplasms/dt [Drug Therapy] MH - Head and Neck Neoplasms/im [Immunology] MH - Humans MH - Jaw Neoplasms/dt [Drug Therapy] MH - Jaw Neoplasms/im [Immunology] MH - Lung Neoplasms/dt [Drug Therapy] MH - Lung Neoplasms/im [Immunology] MH - Male MH - *Programmed Cell Death 1 Receptor/im [Immunology] RN - 0 (Antibodies, Monoclonal) RN - 0 (B7-H1 Antigen) RN - 0 (CD274 protein, human) RN - 0 (PDCD1 protein, human) RN - 0 (Programmed Cell Death 1 Receptor) RS - Adenocarcinoma of lung; Carcinoma, squamous cell of head and neck ES - 1935-5548 IL - 0149-5992 DO - https://dx.doi.org/10.2337/dc15-0889 PT - Case Reports PT - Letter PT - Research Support, Non-U.S. Gov't ID - dc15-0889 [pii] ID - 10.2337/dc15-0889 [doi] PP - ppublish PH - 2015/04/25 [received] PH - 2015/05/18 [accepted] LG - English EP - 20150626 DP - 2015 Sep EZ - 2015/06/28 06:00 DA - 2016/03/29 06:00 DT - 2015/06/28 06:00 YR - 2015 ED - 20160328 RD - 20171116 UP - 20171128 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med8&AN=26116720 <9. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 26310693 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - PubMed-not-MEDLINE AU - Gaudy C AU - Clevy C AU - Monestier S AU - Dubois N AU - Preau Y AU - Mallet S AU - Richard MA AU - Grob JJ AU - Valero R AU - Beliard S FA - Gaudy, Caroline FA - Clevy, Celine FA - Monestier, Sandrine FA - Dubois, Noemie FA - Preau, Yanis FA - Mallet, Stephanie FA - Richard, Marie-Aleth FA - Grob, Jean-Jacques FA - Valero, Rene FA - Beliard, Sophie IN - Gaudy, Caroline. Departments of Dermatology and Oncology, La Timone Hospital, Assistance Publique-Hopitaux de Marseille, Marseille, France INSERM, UMRS 911, Marseille, France. IN - Clevy, Celine. Departments of Dermatology and Oncology, La Timone Hospital, Assistance Publique-Hopitaux de Marseille, Marseille, France. IN - Monestier, Sandrine. Departments of Dermatology and Oncology, La Timone Hospital, Assistance Publique-Hopitaux de Marseille, Marseille, France. IN - Dubois, Noemie. Department of Nutrition, Metabolic Diseases and Endocrinology, La Conception Hospital, Assistance Publique-Hopitaux de Marseille, Marseille, France. IN - Preau, Yanis. Department of Nutrition, Metabolic Diseases and Endocrinology, La Conception Hospital, Assistance Publique-Hopitaux de Marseille, Marseille, France. IN - Mallet, Stephanie. Departments of Dermatology and Oncology, La Timone Hospital, Assistance Publique-Hopitaux de Marseille, Marseille, France. IN - Richard, Marie-Aleth. Departments of Dermatology and Oncology, La Timone Hospital, Assistance Publique-Hopitaux de Marseille, Marseille, France INSERM, UMRS 911, Marseille, France. IN - Grob, Jean-Jacques. Departments of Dermatology and Oncology, La Timone Hospital, Assistance Publique-Hopitaux de Marseille, Marseille, France INSERM, UMRS 911, Marseille, France. IN - Valero, Rene. Department of Nutrition, Metabolic Diseases and Endocrinology, La Conception Hospital, Assistance Publique-Hopitaux de Marseille, Marseille, France Faculty of Medicine, Aix-Marseille University, Marseille, France INSERM, UMR 1062, Marseille, France. IN - Beliard, Sophie. Department of Nutrition, Metabolic Diseases and Endocrinology, La Conception Hospital, Assistance Publique-Hopitaux de Marseille, Marseille, France Faculty of Medicine, Aix-Marseille University, Marseille, France INSERM, UMR 1062, Marseille, France Institut National de la Recherche Agronomique, UMR 1260, Marseille, France sophie.beliard@ap-hm.fr. TI - Anti-PD1 Pembrolizumab Can Induce Exceptional Fulminant Type 1 Diabetes. SO - Diabetes Care. 38(11):e182-3, 2015 Nov AS - Diabetes Care. 38(11):e182-3, 2015 Nov NJ - Diabetes care VO - 38 IP - 11 PG - e182-3 PI - Journal available in: Print-Electronic PI - Citation processed from: Internet JC - eag, 7805975 IO - Diabetes Care CP - United States ES - 1935-5548 IL - 0149-5992 DO - https://dx.doi.org/10.2337/dc15-1331 PT - Letter ID - dc15-1331 [pii] ID - 10.2337/dc15-1331 [doi] PP - ppublish PH - 2015/06/29 [received] PH - 2015/07/23 [accepted] LG - English EP - 20150826 DP - 2015 Nov EZ - 2015/08/28 06:00 DA - 2015/08/28 06:01 DT - 2015/08/28 06:00 YR - 2015 ED - 20160121 RD - 20151023 UP - 20171128 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=prem&AN=26310693 <10. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 25805871 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - MEDLINE AU - Hughes J AU - Vudattu N AU - Sznol M AU - Gettinger S AU - Kluger H AU - Lupsa B AU - Herold KC FA - Hughes, Jing FA - Vudattu, Nalini FA - Sznol, Mario FA - Gettinger, Scott FA - Kluger, Harriet FA - Lupsa, Beatrice FA - Herold, Kevan C IN - Hughes, Jing. Department of Immunobiology, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT Section of Endocrinology and Metabolism, Yale University School of Medicine, New Haven, CT. IN - Vudattu, Nalini. Department of Immunobiology, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT. IN - Sznol, Mario. Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT. IN - Gettinger, Scott. Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT. IN - Kluger, Harriet. Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT. IN - Lupsa, Beatrice. Section of Endocrinology and Metabolism, Yale University School of Medicine, New Haven, CT. IN - Herold, Kevan C. Department of Immunobiology, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT Section of Endocrinology and Metabolism, Yale University School of Medicine, New Haven, CT kevan.herold@yale.edu. TI - Precipitation of autoimmune diabetes with anti-PD-1 immunotherapy. SO - Diabetes Care. 38(4):e55-7, 2015 Apr AS - Diabetes Care. 38(4):e55-7, 2015 Apr NJ - Diabetes care VO - 38 IP - 4 PG - e55-7 PI - Journal available in: Print PI - Citation processed from: Internet JC - eag, 7805975 IO - Diabetes Care PM - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370325 SB - Index Medicus CP - United States MH - Aged, 80 and over MH - Antibodies, Monoclonal/ae [Adverse Effects] MH - *Antibodies, Monoclonal/tu [Therapeutic Use] MH - Autoimmunity MH - Diabetes Mellitus, Type 1/bl [Blood] MH - *Diabetes Mellitus, Type 1/ci [Chemically Induced] MH - Diabetes Mellitus, Type 1/im [Immunology] MH - Diabetes Mellitus, Type 1/pa [Pathology] MH - Disease Progression MH - Female MH - Humans MH - *Immunotherapy/ae [Adverse Effects] MH - Male MH - Middle Aged MH - Neoplasms/im [Immunology] MH - Neoplasms/th [Therapy] MH - *Programmed Cell Death 1 Receptor/im [Immunology] RN - 0 (Antibodies, Monoclonal) RN - 0 (PDCD1 protein, human) RN - 0 (Programmed Cell Death 1 Receptor) RN - 31YO63LBSN (nivolumab) ES - 1935-5548 IL - 0149-5992 DO - https://dx.doi.org/10.2337/dc14-2349 PT - Case Reports PT - Letter PT - Research Support, N.I.H., Extramural ID - 38/4/e55 [pii] ID - 10.2337/dc14-2349 [doi] ID - PMC4370325 [pmc] PP - ppublish GI - No: R01 DK057846 Organization: (DK) *NIDDK NIH HHS* Country: United States GI - No: T32 DK007058 Organization: (DK) *NIDDK NIH HHS* Country: United States GI - No: R01DK057846 Organization: (DK) *NIDDK NIH HHS* Country: United States GI - No: T32DK007058 Organization: (DK) *NIDDK NIH HHS* Country: United States LG - English DP - 2015 Apr EZ - 2015/03/26 06:00 DA - 2015/09/12 06:00 DT - 2015/03/26 06:00 YR - 2015 ED - 20150911 RD - 20161019 UP - 20171128 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med8&AN=25805871 <11. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 23607982 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - MEDLINE AU - de Hollanda A AU - Aranda GB AU - Mora M AU - Gaba L AU - Halperin I FA - de Hollanda, Ana FA - Aranda, Gloria B FA - Mora, Mireia FA - Gaba, Lydia FA - Halperin, Irene IN - de Hollanda, Ana. Servicio de Endocrinologia y Nutricion, Hospital Clinic, Universitat de Barcelona, Barcelona, Espana. Electronic address: amdehol@clinic.ub.es. TI - [Ipilimumab, a cause of autoimmune hypophysitis]. [Spanish] OT - Ipilimumab, una causa de hipofisitis autoinmunitaria. SO - Endocrinologia y Nutricion. 60(10):604-6, 2013 Dec AS - Endocrinol. nutr.. 60(10):604-6, 2013 Dec NJ - Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion VO - 60 IP - 10 PG - 604-6 PI - Journal available in: Print-Electronic PI - Citation processed from: Internet JC - 100886482 IO - Endocrinol Nutr SB - Index Medicus CP - Spain MH - Adult MH - Aged MH - *Antibodies, Monoclonal/ae [Adverse Effects] MH - *Autoimmune Diseases/ci [Chemically Induced] MH - Female MH - Humans MH - *Inflammation/ci [Chemically Induced] MH - *Inflammation/im [Immunology] MH - Ipilimumab MH - Male MH - Middle Aged MH - *Pituitary Diseases/ci [Chemically Induced] RN - 0 (Antibodies, Monoclonal) RN - 0 (Ipilimumab) ES - 1579-2021 IL - 1575-0922 DI - S1575-0922(13)00088-0 DO - https://dx.doi.org/10.1016/j.endonu.2013.01.007 PT - Case Reports PT - Letter ID - S1575-0922(13)00088-0 [pii] ID - 10.1016/j.endonu.2013.01.007 [doi] PP - ppublish PH - 2012/12/06 [received] PH - 2013/01/20 [revised] PH - 2013/01/22 [accepted] LG - Spanish EP - 20130420 DP - 2013 Dec EZ - 2013/04/24 06:00 DA - 2015/04/10 06:00 DT - 2013/04/24 06:00 YR - 2013 ED - 20150409 RD - 20171116 UP - 20171128 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med7&AN=23607982 <12. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 25164840 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - MEDLINE AU - De Sousa SM AU - Long GV AU - Tonks KT FA - De Sousa, Sunita M C FA - Long, Georgina V FA - Tonks, Katherine T IN - De Sousa, Sunita M C. Department of Endocrinology, St Vincent's Hospital, Sydney, NSW, Australia. s.desousa@garvan.org.au. IN - Long, Georgina V. Melanoma Institute Australia, Sydney, NSW, Australia. IN - Tonks, Katherine T. Diabetes and Metabolism Division, Garvan Institute of Medical Research, Sydney, NSW, Australia. TI - Ipilimumab-induced hypophysitis: early Australian experience. SO - Medical Journal of Australia. 201(4):198-9, 2014 Aug 18 AS - Med J Aust. 201(4):198-9, 2014 Aug 18 NJ - The Medical journal of Australia VO - 201 IP - 4 PG - 198-9 PI - Journal available in: Print PI - Citation processed from: Internet JC - 0400714, m26 IO - Med. J. Aust. SB - Index Medicus CP - Australia MH - Antibodies, Monoclonal/ad [Administration & Dosage] MH - *Antibodies, Monoclonal/ae [Adverse Effects] MH - Antineoplastic Agents/ad [Administration & Dosage] MH - *Antineoplastic Agents/ae [Adverse Effects] MH - Australia MH - Disease Progression MH - Glucocorticoids/tu [Therapeutic Use] MH - Humans MH - *Hypopituitarism/ci [Chemically Induced] MH - Hypopituitarism/dt [Drug Therapy] MH - Hypopituitarism/im [Immunology] MH - *Hypopituitarism/pa [Pathology] MH - Ipilimumab MH - Male MH - Melanoma/dt [Drug Therapy] MH - Melanoma/sc [Secondary] MH - Middle Aged MH - Prednisolone/tu [Therapeutic Use] MH - Skin Neoplasms/dt [Drug Therapy] MH - Skin Neoplasms/sc [Secondary] RN - 0 (Antibodies, Monoclonal) RN - 0 (Antineoplastic Agents) RN - 0 (Glucocorticoids) RN - 0 (Ipilimumab) RN - 9PHQ9Y1OLM (Prednisolone) ES - 1326-5377 IL - 0025-729X PT - Case Reports PT - Letter ID - 10.5694/mja14.00803 [pii] PP - ppublish PH - 2014/06/03 [received] PH - 2014/07/10 [accepted] LG - English DP - 2014 Aug 18 EZ - 2014/08/29 06:00 DA - 2014/12/30 06:00 DT - 2014/08/29 06:00 YR - 2014 ED - 20141224 RD - 20171116 UP - 20171128 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med8&AN=25164840 <13. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 24398505 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - MEDLINE AU - Borodic GE AU - Hinkle D FA - Borodic, Gary E FA - Hinkle, David TI - Ipilimumab-induced orbital inflammation resembling Graves disease with subsequent development of systemic hyperthyroidism from CTLA-4 receptor suppression. SO - Ophthalmic Plastic & Reconstructive Surgery. 30(1):83, 2014 Jan-Feb AS - Ophthal Plast Reconstr Surg. 30(1):83, 2014 Jan-Feb NJ - Ophthalmic plastic and reconstructive surgery VO - 30 IP - 1 PG - 83 PI - Journal available in: Print PI - Citation processed from: Internet JC - ay2, 8508431 IO - Ophthal Plast Reconstr Surg SB - Index Medicus CP - United States MH - *Antibodies, Monoclonal/ae [Adverse Effects] MH - *Antineoplastic Agents/ae [Adverse Effects] MH - *CTLA-4 Antigen/ai [Antagonists & Inhibitors] MH - *Graves Disease/ci [Chemically Induced] MH - Graves Disease/di [Diagnosis] MH - Humans MH - *Hyperthyroidism/ci [Chemically Induced] MH - Hyperthyroidism/di [Diagnosis] MH - Ipilimumab MH - Neoplasms, Unknown Primary/dt [Drug Therapy] MH - *Orbital Myositis/ci [Chemically Induced] MH - Orbital Myositis/di [Diagnosis] RN - 0 (Antibodies, Monoclonal) RN - 0 (Antineoplastic Agents) RN - 0 (CTLA-4 Antigen) RN - 0 (CTLA4 protein, human) RN - 0 (Ipilimumab) ES - 1537-2677 IL - 0740-9303 DO - https://dx.doi.org/10.1097/IOP.0000000000000033 PT - Letter ID - 10.1097/IOP.0000000000000033 [doi] ID - 00002341-201401000-00029 [pii] PP - ppublish LG - English DP - 2014 Jan-Feb EZ - 2014/01/09 06:00 DA - 2014/06/27 06:00 DT - 2014/01/09 06:00 YR - 2014 ED - 20140626 RD - 20171116 UP - 20171128 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med8&AN=24398505 <14. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 23779068 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - MEDLINE AU - Corsello SM AU - Salvatori R AU - Barnabei A AU - De Vecchis L AU - Marchetti P AU - Torino F FA - Corsello, Salvatore Maria FA - Salvatori, Roberto FA - Barnabei, Agnese FA - De Vecchis, Liana FA - Marchetti, Paolo FA - Torino, Francesco TI - Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not). SO - Cancer Chemotherapy & Pharmacology. 72(2):489-90, 2013 Aug AS - Cancer Chemother Pharmacol. 72(2):489-90, 2013 Aug NJ - Cancer chemotherapy and pharmacology VO - 72 IP - 2 PG - 489-90 PI - Journal available in: Print-Electronic PI - Citation processed from: Internet JC - c9s, 7806519 IO - Cancer Chemother. Pharmacol. SB - Index Medicus CP - Germany MH - *Adrenal Cortex Hormones/tu [Therapeutic Use] MH - Anti-Inflammatory Agents/tu [Therapeutic Use] MH - *Antibodies, Monoclonal/ae [Adverse Effects] MH - Antibodies, Monoclonal/tu [Therapeutic Use] MH - *Endocrine System Diseases/ci [Chemically Induced] MH - *Endocrine System Diseases/dt [Drug Therapy] MH - Humans MH - Hypopituitarism/ci [Chemically Induced] MH - Ipilimumab MH - Methylprednisolone/tu [Therapeutic Use] MH - Neoplasms/co [Complications] MH - Neoplasms/dt [Drug Therapy] MH - Prednisone/tu [Therapeutic Use] MH - Thyroid Diseases/ci [Chemically Induced] MH - Thyroid Diseases/dt [Drug Therapy] RN - 0 (Adrenal Cortex Hormones) RN - 0 (Anti-Inflammatory Agents) RN - 0 (Antibodies, Monoclonal) RN - 0 (Ipilimumab) RN - VB0R961HZT (Prednisone) RN - X4W7ZR7023 (Methylprednisolone) ES - 1432-0843 IL - 0344-5704 DO - https://dx.doi.org/10.1007/s00280-013-2213-y PT - Letter ID - 10.1007/s00280-013-2213-y [doi] PP - ppublish PH - 2013/05/13 [received] PH - 2013/06/10 [accepted] LG - English EP - 20130619 DP - 2013 Aug EZ - 2013/06/20 06:00 DA - 2013/09/26 06:00 DT - 2013/06/20 06:00 YR - 2013 ED - 20130924 RD - 20171116 UP - 20171128 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med7&AN=23779068 <15. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 28945828 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - In-Process AU - Otsubo K AU - Nakatomi K AU - Furukawa R AU - Ashida K AU - Yoneshima Y AU - Nakanishi Y AU - Okamoto I FA - Otsubo, K FA - Nakatomi, K FA - Furukawa, R FA - Ashida, K FA - Yoneshima, Y FA - Nakanishi, Y FA - Okamoto, I IN - Otsubo, K. Research Institute for Diseases of the Chest. IN - Nakatomi, K. Research Institute for Diseases of the Chest. IN - Furukawa, R. Research Institute for Diseases of the Chest. IN - Ashida, K. Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. IN - Yoneshima, Y. Research Institute for Diseases of the Chest. IN - Nakanishi, Y. Research Institute for Diseases of the Chest. IN - Okamoto, I. Research Institute for Diseases of the Chest. TI - Two cases of late-onset secondary adrenal insufficiency after discontinuation of nivolumab. SO - Annals of Oncology. 28(12):3106-3107, 2017 12 01 AS - Ann Oncol. 28(12):3106-3107, 2017 12 01 NJ - Annals of oncology : official journal of the European Society for Medical Oncology VO - 28 IP - 12 PG - 3106-3107 PI - Journal available in: Print PI - Citation processed from: Internet JC - ayf, 9007735 IO - Ann. Oncol. CP - England ES - 1569-8041 IL - 0923-7534 DO - https://dx.doi.org/10.1093/annonc/mdx497 PT - Letter ID - 4098873 [pii] ID - 10.1093/annonc/mdx497 [doi] PP - ppublish LG - English DP - 2017 12 01 EZ - 2017/09/26 06:00 DA - 2017/09/26 06:00 DT - 2017/09/26 06:00 YR - 2017 RD - 20180117 UP - 20180118 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=prem&AN=28945828 <16. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 28043983 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - In-Process AU - Telo GH AU - Carvalhal GF AU - Cauduro CGS AU - Webber VS AU - Barrios CH AU - Fay AP FA - Telo, G H FA - Carvalhal, G F FA - Cauduro, C G S FA - Webber, V S FA - Barrios, C H FA - Fay, A P IN - Telo, G H. Endocrinology Department, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre. IN - Carvalhal, G F. School of Medicine, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul 90619-900, Brazil. IN - Cauduro, C G S. School of Medicine, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul 90619-900, Brazil. IN - Webber, V S. Clinical Research Center, PUCRS, Porto Alegre, Brazil. IN - Barrios, C H. School of Medicine, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul 90619-900, Brazil. IN - Barrios, C H. Clinical Research Center, PUCRS, Porto Alegre, Brazil. IN - Barrios, C H. Medical Oncology, Hospital do Cancer Mae de Deus, Porto Alegre, Brazil. IN - Barrios, C H. Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil. IN - Fay, A P. School of Medicine, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul 90619-900, Brazil. IN - Fay, A P. Clinical Research Center, PUCRS, Porto Alegre, Brazil. IN - Fay, A P. Medical Oncology, Hospital do Cancer Mae de Deus, Porto Alegre, Brazil. IN - Fay, A P. Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil. TI - Fulminant type 1 diabetes caused by dual immune checkpoint blockade in metastatic renal cell carcinoma. SO - Annals of Oncology. 28(1):191-192, 2017 01 01 AS - Ann Oncol. 28(1):191-192, 2017 01 01 NJ - Annals of oncology : official journal of the European Society for Medical Oncology VO - 28 IP - 1 PG - 191-192 PI - Journal available in: Print PI - Citation processed from: Internet JC - ayf, 9007735 IO - Ann. Oncol. CP - England ES - 1569-8041 IL - 0923-7534 DO - https://dx.doi.org/10.1093/annonc/mdw447 PT - Letter ID - mdw447 [pii] ID - 10.1093/annonc/mdw447 [doi] PP - ppublish LG - English DP - 2017 01 01 EZ - 2017/01/04 06:00 DA - 2017/01/04 06:00 DT - 2017/01/04 06:00 YR - 2017 RD - 20180117 UP - 20180117 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=prem&AN=28043983 <17. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 29098805 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - In-Process AU - Kumagai R AU - Muramatsu A AU - Nakajima R AU - Fujii M AU - Kaino K AU - Katakura Y AU - Okumura N AU - Ohara G AU - Kagohashi K AU - Satoh H AU - Yagyu H FA - Kumagai, Ryo FA - Muramatsu, Aiko FA - Nakajima, Rikako FA - Fujii, Masanao FA - Kaino, Kenta FA - Katakura, Yukino FA - Okumura, Nobuhito FA - Ohara, Gen FA - Kagohashi, Katsunori FA - Satoh, Hiroaki FA - Yagyu, Hiroaki IN - Kumagai, Ryo. Department of Endocrinology and Metabolism, Tsukuba University Hospital Mito Clinical Education and Training Center, Mito Kyodo General Hospital, Mito, Ibaraki, Japan. IN - Muramatsu, Aiko. Department of Endocrinology and Metabolism, Tsukuba University Hospital Mito Clinical Education and Training Center, Mito Kyodo General Hospital, Mito, Ibaraki, Japan. IN - Nakajima, Rikako. Department of General Medicine, Tsukuba University Hospital Mito Clinical Education and Training Center, Mito Kyodo General Hospital, Mito, Ibaraki, Japan. IN - Fujii, Masanao. Department of Endocrinology and Metabolism, Tsukuba University Hospital Mito Clinical Education and Training Center, Mito Kyodo General Hospital, Mito, Ibaraki, Japan. IN - Kaino, Kenta. Department of Endocrinology and Metabolism, Tsukuba University Hospital Mito Clinical Education and Training Center, Mito Kyodo General Hospital, Mito, Ibaraki, Japan. IN - Katakura, Yukino. Department of Endocrinology and Metabolism, Tsukuba University Hospital Mito Clinical Education and Training Center, Mito Kyodo General Hospital, Mito, Ibaraki, Japan. IN - Okumura, Nobuhito. Department of General Medicine, Tsukuba University Hospital Mito Clinical Education and Training Center, Mito Kyodo General Hospital, Mito, Ibaraki, Japan. IN - Ohara, Gen. Department of Respiratory Medicine, Tsukuba University Hospital Mito Clinical Education and Training Center, Mito Kyodo General Hospital, Mito, Ibaraki, Japan. IN - Kagohashi, Katsunori. Department of Respiratory Medicine, Tsukuba University Hospital Mito Clinical Education and Training Center, Mito Kyodo General Hospital, Mito, Ibaraki, Japan. IN - Satoh, Hiroaki. Department of Respiratory Medicine, Tsukuba University Hospital Mito Clinical Education and Training Center, Mito Kyodo General Hospital, Mito, Ibaraki, Japan. IN - Yagyu, Hiroaki. Department of Endocrinology and Metabolism, Tsukuba University Hospital Mito Clinical Education and Training Center, Mito Kyodo General Hospital, Mito, Ibaraki, Japan. TI - Acute-onset type 1 diabetes mellitus caused by nivolumab in a patient with advanced pulmonary adenocarcinoma. SO - Journal of Diabetes Investigation. 8(6):798-799, 2017 Nov AS - J. diabetes investig.. 8(6):798-799, 2017 Nov NJ - Journal of diabetes investigation VO - 8 IP - 6 PG - 798-799 PI - Journal available in: Print PI - Citation processed from: Internet JC - 101520702 IO - J Diabetes Investig CP - Japan AB - A case of acute-onset type 1 diabetes mellitus concomitant with pneumonitis and vitiligo is described. Copyright © 2017 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd. ES - 2040-1124 IL - 2040-1116 DO - https://dx.doi.org/10.1111/jdi.12627 PT - Letter ID - 10.1111/jdi.12627 [doi] ID - PMC5668515 [pmc] PP - ppublish PH - 2016/12/12 [received] PH - 2017/01/16 [revised] PH - 2017/01/16 [accepted] LG - English DP - 2017 Nov EZ - 2017/11/04 06:00 DA - 2017/11/04 06:00 DT - 2017/11/04 06:00 YR - 2017 RD - 20171219 UP - 20171220 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=prem&AN=29098805 <18. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 27451306 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - In-Process AU - Miller AH AU - Brock P AU - Jim Yeung SC FA - Miller, Adam H FA - Brock, Patricia FA - Jim Yeung, Sai-Ching IN - Miller, Adam H. Department of Emergency Medicine, University of Texas MD Anderson Cancer Center, Houston, TX. IN - Brock, Patricia. Department of Emergency Medicine, University of Texas MD Anderson Cancer Center, Houston, TX. IN - Jim Yeung, Sai-Ching. Department of Emergency Medicine, University of Texas MD Anderson Cancer Center, Houston, TX. TI - Pituitary Dysfunction: A Case Series of Immune Checkpoint Inhibitor-Related Hypophysitis in an Emergency Department. SO - Annals of Emergency Medicine. 68(2):249-50, 2016 08 AS - Ann Emerg Med. 68(2):249-50, 2016 08 NJ - Annals of emergency medicine VO - 68 IP - 2 PG - 249-50 PI - Journal available in: Print PI - Citation processed from: Internet JC - 8002646 IO - Ann Emerg Med SB - Core Clinical Journals (AIM) SB - Index Medicus CP - United States ES - 1097-6760 IL - 0196-0644 DI - S0196-0644(16)30053-1 DO - https://dx.doi.org/10.1016/j.annemergmed.2016.03.048 PT - Letter PT - Research Support, Non-U.S. Gov't ID - S0196-0644(16)30053-1 [pii] ID - 10.1016/j.annemergmed.2016.03.048 [doi] PP - ppublish PH - 2016/03/17 [received] LG - English DP - 2016 08 EZ - 2016/07/28 06:00 DA - 2016/07/28 06:00 DT - 2016/07/25 06:00 YR - 2016 RD - 20171130 UP - 20171130 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=prem&AN=27451306 <19. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 29074210 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - In-Data-Review AU - Marchand L AU - Paulus V AU - Fabien N AU - Perol M AU - Thivolet C AU - Vouillarmet J AU - Saintigny P FA - Marchand, Lucien FA - Paulus, Valerie FA - Fabien, Nicole FA - Perol, Maurice FA - Thivolet, Charles FA - Vouillarmet, Julien FA - Saintigny, Pierre IN - Marchand, Lucien. Department of Endocrinology and Diabetes, Hospices Civils de Lyon, Lyon-Sud Hospital, Pierre-Benite, France. Electronic address: Lucien.marchand@chu-lyon.fr. IN - Paulus, Valerie. Department of Medical Oncology, Leon Berard Cancer Center, Lyon, France. IN - Fabien, Nicole. Department of Immunology, Hospices Civils de Lyon, Lyon-Sud Hospital, Pierre-Benite, France. IN - Perol, Maurice. Department of Medical Oncology, Leon Berard Cancer Center, Lyon, France. IN - Thivolet, Charles. Department of Endocrinology and Diabetes, Hospices Civils de Lyon, Lyon-Sud Hospital, Pierre-Benite, France. IN - Vouillarmet, Julien. Department of Endocrinology and Diabetes, Hospices Civils de Lyon, Lyon-Sud Hospital, Pierre-Benite, France. IN - Saintigny, Pierre. Department of Medical Oncology, Leon Berard Cancer Center, Lyon, France. TI - Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response. SO - Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer. 12(11):e182-e184, 2017 Nov AS - J Thorac Oncol. 12(11):e182-e184, 2017 Nov NJ - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer VO - 12 IP - 11 PG - e182-e184 PI - Journal available in: Print PI - Citation processed from: Internet JC - 101274235 IO - J Thorac Oncol CP - United States ES - 1556-1380 IL - 1556-0864 DI - S1556-0864(17)30618-4 DO - https://dx.doi.org/10.1016/j.jtho.2017.07.021 PT - Letter ID - S1556-0864(17)30618-4 [pii] ID - 10.1016/j.jtho.2017.07.021 [doi] PP - ppublish PH - 2017/07/06 [received] PH - 2017/07/08 [revised] PH - 2017/07/09 [accepted] LG - English DP - 2017 Nov EZ - 2017/10/28 06:00 DA - 2017/10/28 06:00 DT - 2017/10/28 06:00 YR - 2017 RD - 20171027 UP - 20171128 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=prem&AN=29074210 <20. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 28295551 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - In-Data-Review AU - Oda T AU - Sawada Y AU - Okada E AU - Yamaguchi T AU - Ohmori S AU - Haruyama S AU - Yoshioka M AU - Nakamura M FA - Oda, Tomoko FA - Sawada, Yu FA - Okada, Etsuko FA - Yamaguchi, Takashi FA - Ohmori, Shun FA - Haruyama, Sanehito FA - Yoshioka, Manabu FA - Nakamura, Motonobu IN - Oda, Tomoko. Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan. IN - Sawada, Yu. Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan. IN - Okada, Etsuko. Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan. IN - Yamaguchi, Takashi. Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan. IN - Ohmori, Shun. Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan. IN - Haruyama, Sanehito. Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan. IN - Yoshioka, Manabu. Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan. IN - Nakamura, Motonobu. Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan. TI - Hypopituitarism and hypothyroidism following atrioventricular block during nivolumab treatment. SO - Journal of Dermatology. 44(6):e144-e145, 2017 Jun AS - J Dermatol. 44(6):e144-e145, 2017 Jun NJ - The Journal of dermatology VO - 44 IP - 6 PG - e144-e145 PI - Journal available in: Print-Electronic PI - Citation processed from: Internet JC - hz7, 7600545 IO - J. Dermatol. CP - England ES - 1346-8138 IL - 0385-2407 DO - https://dx.doi.org/10.1111/1346-8138.13797 PT - Letter ID - 10.1111/1346-8138.13797 [doi] PP - ppublish LG - English EP - 20170311 DP - 2017 Jun EZ - 2017/03/16 06:00 DA - 2017/03/16 06:00 DT - 2017/03/16 06:00 YR - 2017 RD - 20170605 UP - 20171128 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=prem&AN=28295551 <21. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 28084260 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - In-Data-Review AU - Singh D AU - Hsu CC AU - Kwan GN AU - Bhuta S FA - Singh, Dalveer FA - Hsu, Charlie Chia-Tsong FA - Kwan, Gigi Nga Chi FA - Bhuta, Sandeep IN - Singh, Dalveer. Department of Medical Imaging, School of Medicine, University of Queensland, Brisbane, Queensland, Australia. IN - Hsu, Charlie Chia-Tsong. Department of Medical Imaging, Gold Coast University Hospital, Southport, Queensland, Australia. IN - Kwan, Gigi Nga Chi. Department of Medical Imaging, Gold Coast University Hospital, Southport, Queensland, Australia. IN - Bhuta, Sandeep. Department of Medical Imaging, Gold Coast University Hospital, Southport, Queensland, Australia. TI - Ipilimumab-induced hypophysitis and ileocolitis: Serial pituitary MRI findings. SO - Neurology India. 65(1):165-166, 2017 Jan-Feb AS - Neurol India. 65(1):165-166, 2017 Jan-Feb NJ - Neurology India VO - 65 IP - 1 PG - 165-166 PI - Journal available in: Print PI - Citation processed from: Print JC - nyb, 0042005 IO - Neurol India CP - India IS - 0028-3886 IL - 0028-3886 DO - https://dx.doi.org/10.4103/0028-3886.198182 PT - Letter ID - ni_2017_65_1_165_198182 [pii] ID - 10.4103/0028-3886.198182 [doi] PP - ppublish LG - English DP - 2017 Jan-Feb EZ - 2017/01/14 06:00 DA - 2017/01/14 06:00 DT - 2017/01/14 06:00 YR - 2017 RD - 20170113 UP - 20171128 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=prem&AN=28084260 <22. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 27864834 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - In-Data-Review AU - Ohnuma T AU - Matsuzawa T AU - Kinoshita M AU - Sano S AU - Kawamura T AU - Shimada S AU - Inozume T FA - Ohnuma, Takehiro FA - Matsuzawa, Takamitsu FA - Kinoshita, Manao FA - Sano, Shinya FA - Kawamura, Tatsuyoshi FA - Shimada, Shinji FA - Inozume, Takashi IN - Ohnuma, Takehiro. Department of Dermatology, University of Yamanashi, Chuo, Japan. IN - Matsuzawa, Takamitsu. Department of Dermatology, University of Yamanashi, Chuo, Japan. IN - Kinoshita, Manao. Department of Dermatology, University of Yamanashi, Chuo, Japan. IN - Sano, Shinya. Department of Dermatology, University of Yamanashi, Chuo, Japan. IN - Kawamura, Tatsuyoshi. Department of Dermatology, University of Yamanashi, Chuo, Japan. IN - Shimada, Shinji. Department of Dermatology, University of Yamanashi, Chuo, Japan. IN - Inozume, Takashi. Department of Dermatology, University of Yamanashi, Chuo, Japan. TI - Case of metastatic uveal melanoma in which an antitumor effect appeared after ipilimumab discontinuation due to autoimmune hypophysitis. SO - Journal of Dermatology. 44(11):1325-1326, 2017 Nov AS - J Dermatol. 44(11):1325-1326, 2017 Nov NJ - The Journal of dermatology VO - 44 IP - 11 PG - 1325-1326 PI - Journal available in: Print-Electronic PI - Citation processed from: Internet JC - hz7, 7600545 IO - J. Dermatol. CP - England ES - 1346-8138 IL - 0385-2407 DO - https://dx.doi.org/10.1111/1346-8138.13692 PT - Letter ID - 10.1111/1346-8138.13692 [doi] PP - ppublish LG - English EP - 20161118 DP - 2017 Nov EZ - 2016/11/20 06:00 DA - 2016/11/20 06:00 DT - 2016/11/20 06:00 YR - 2017 RD - 20171103 UP - 20171128 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=prem&AN=27864834 <23. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 27608187 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - In-Data-Review AU - Narahira A AU - Yanagi T AU - Cho KY AU - Nakamura A AU - Miyoshi H AU - Hata H AU - Imafuku K AU - Kitamura S AU - Shimizu H FA - Narahira, Atsushi FA - Yanagi, Teruki FA - Cho, Kyu Yong FA - Nakamura, Akinobu FA - Miyoshi, Hideaki FA - Hata, Hiroo FA - Imafuku, Keisuke FA - Kitamura, Shinya FA - Shimizu, Hiroshi IN - Narahira, Atsushi. Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan. IN - Yanagi, Teruki. Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan. IN - Cho, Kyu Yong. Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo, Japan. IN - Nakamura, Akinobu. Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo, Japan. IN - Miyoshi, Hideaki. Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo, Japan. IN - Hata, Hiroo. Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan. IN - Imafuku, Keisuke. Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan. IN - Kitamura, Shinya. Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan. IN - Shimizu, Hiroshi. Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan. TI - Isolated adrenocorticotropic hormone deficiency associated with nivolumab therapy. SO - Journal of Dermatology. 44(4):e70, 2017 Apr AS - J Dermatol. 44(4):e70, 2017 Apr NJ - The Journal of dermatology VO - 44 IP - 4 PG - e70 PI - Journal available in: Print-Electronic PI - Citation processed from: Internet JC - hz7, 7600545 IO - J. Dermatol. CP - England ES - 1346-8138 IL - 0385-2407 DO - https://dx.doi.org/10.1111/1346-8138.13571 PT - Letter ID - 10.1111/1346-8138.13571 [doi] PP - ppublish LG - English EP - 20160908 DP - 2017 Apr EZ - 2016/09/09 06:00 DA - 2016/09/09 06:00 DT - 2016/09/09 06:00 YR - 2017 RD - 20170405 UP - 20171128 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=prem&AN=27608187 <24. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 27440178 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - In-Data-Review AU - Fujimura T AU - Kambayashi Y AU - Furudate S AU - Kakizaki A AU - Hidaka T AU - Haga T AU - Hashimoto A AU - Morimoto R AU - Aiba S FA - Fujimura, Taku FA - Kambayashi, Yumi FA - Furudate, Sadanori FA - Kakizaki, Aya FA - Hidaka, Takanori FA - Haga, Takahiro FA - Hashimoto, Akira FA - Morimoto, Ryo FA - Aiba, Setsuya IN - Fujimura, Taku. Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan. IN - Kambayashi, Yumi. Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan. IN - Furudate, Sadanori. Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan. IN - Kakizaki, Aya. Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan. IN - Hidaka, Takanori. Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan. IN - Haga, Takahiro. Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan. IN - Hashimoto, Akira. Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan. IN - Morimoto, Ryo. Division of Nephrology, Endocrinology and Vascular Medicine, Department of Medicine, Tohoku University Hospital, Sendai, Japan. IN - Aiba, Setsuya. Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan. TI - Isolated adrenocorticotropic hormone deficiency possibly caused by nivolumab in a metastatic melanoma patient. SO - Journal of Dermatology. 44(3):e13-e14, 2017 Mar AS - J Dermatol. 44(3):e13-e14, 2017 Mar NJ - The Journal of dermatology VO - 44 IP - 3 PG - e13-e14 PI - Journal available in: Print-Electronic PI - Citation processed from: Internet JC - hz7, 7600545 IO - J. Dermatol. CP - England ES - 1346-8138 IL - 0385-2407 DO - https://dx.doi.org/10.1111/1346-8138.13532 PT - Letter ID - 10.1111/1346-8138.13532 [doi] PP - ppublish LG - English EP - 20160721 DP - 2017 Mar EZ - 2016/07/22 06:00 DA - 2016/07/22 06:00 DT - 2016/07/22 06:00 YR - 2017 RD - 20170303 UP - 20171128 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=prem&AN=27440178 <25. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 27334247 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - In-Data-Review AU - Teramoto Y AU - Nakamura Y AU - Asami Y AU - Imamura T AU - Takahira S AU - Nemoto M AU - Sakai G AU - Shimada A AU - Noda M AU - Yamamoto A FA - Teramoto, Yukiko FA - Nakamura, Yasuhiro FA - Asami, Yuri FA - Imamura, Taichi FA - Takahira, Shuji FA - Nemoto, Manabu FA - Sakai, Gota FA - Shimada, Akira FA - Noda, Mitsuhiko FA - Yamamoto, Akifumi IN - Teramoto, Yukiko. Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan. IN - Nakamura, Yasuhiro. Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan. IN - Asami, Yuri. Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan. IN - Imamura, Taichi. Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan. IN - Takahira, Shuji. Division of Traumatology and Emergency Acute Medicine, Saitama Medical University International Medical Center, Saitama, Japan. IN - Nemoto, Manabu. Division of Traumatology and Emergency Acute Medicine, Saitama Medical University International Medical Center, Saitama, Japan. IN - Sakai, Gota. Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan. IN - Shimada, Akira. Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan. IN - Noda, Mitsuhiko. Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan. IN - Yamamoto, Akifumi. Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan. TI - Case of type 1 diabetes associated with less-dose nivolumab therapy in a melanoma patient. SO - Journal of Dermatology. 44(5):605-606, 2017 May AS - J Dermatol. 44(5):605-606, 2017 May NJ - The Journal of dermatology VO - 44 IP - 5 PG - 605-606 PI - Journal available in: Print-Electronic PI - Citation processed from: Internet JC - hz7, 7600545 IO - J. Dermatol. CP - England ES - 1346-8138 IL - 0385-2407 DO - https://dx.doi.org/10.1111/1346-8138.13486 PT - Letter ID - 10.1111/1346-8138.13486 [doi] PP - ppublish LG - English EP - 20160623 DP - 2017 May EZ - 2016/06/24 06:00 DA - 2016/06/24 06:00 DT - 2016/06/24 06:00 YR - 2017 RD - 20170427 UP - 20171128 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=prem&AN=27334247 <26. > VN - Ovid Technologies DB - Ovid MEDLINE(R) UI - 28648834 VI - 1 RO - From MEDLINE, a database of the U.S. National Library of Medicine. ST - Publisher AU - Atkins PW AU - Thompson DM FA - Atkins, P W FA - Thompson, D M IN - Atkins, P W. Division of Endocrinology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. IN - Thompson, D M. Division of Endocrinology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: David.Thompson@vch.ca. TI - Combination avelumab and utomilumab immunotherapy can induce diabetic ketoacidosis. SO - Diabetes & Metabolism. 2017 Jun 22 AS - Diabetes Metab. 2017 Jun 22 NJ - Diabetes & metabolism PI - Journal available in: Print-Electronic PI - Citation processed from: Internet JC - cki, 9607599 IO - Diabetes Metab. CP - France ES - 1878-1780 IL - 1262-3636 DI - S1262-3636(17)30103-9 DO - https://dx.doi.org/10.1016/j.diabet.2017.05.005 PT - Letter ID - S1262-3636(17)30103-9 [pii] ID - 10.1016/j.diabet.2017.05.005 [doi] PP - aheadofprint PH - 2017/05/18 [received] PH - 2017/05/23 [accepted] LG - English EP - 20170622 DP - 2017 Jun 22 EZ - 2017/06/27 06:00 DA - 2017/06/27 06:00 DT - 2017/06/27 06:00 YR - 2017 RD - 20170626 UP - 20171128 XL - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=medp&AN=28648834